# Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis

> **NCT04932395** · PHASE4 · UNKNOWN · sponsor: **China Academy of Chinese Medical Sciences** · enrollment: 400 (estimated)

## Conditions studied

- Cardiac Neurosis

## Interventions

- **DRUG:** Anshen Buxin Liuwei Pill
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04932395
- **Lead sponsor:** China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-22
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2022-11-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04932395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04932395, "Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04932395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*